ACHE and Alzheimer disease: On the contrary, the increment in AChE activity was mitigated in Nobiletin-treated mice by 45.8% as contrasted to STZ-AD mice and the effect of STZ was ameliorated by Nobiletin which enhanced ACh levels by approximately 80%.